ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,448,750 | -13.7% | 53,917 | +14.5% | 0.08% | -11.1% |
| Q2 2023 | $1,679,122 | +25.2% | 47,087 | -10.8% | 0.09% | +8.4% |
| Q1 2023 | $1,341,171 | +83.7% | 52,802 | +193.4% | 0.08% | +76.6% |
| Q4 2022 | $730,039 | +26.3% | 17,999 | +3.0% | 0.05% | +11.9% |
| Q3 2022 | $578,000 | -7.7% | 17,476 | -1.8% | 0.04% | +5.0% |
| Q2 2022 | $626,000 | -33.1% | 17,792 | -12.6% | 0.04% | +2.6% |
| Q1 2022 | $936,000 | -37.0% | 20,359 | -9.2% | 0.04% | -20.4% |
| Q4 2021 | $1,486,000 | -4.4% | 22,412 | -10.0% | 0.05% | -5.8% |
| Q3 2021 | $1,554,000 | +121.4% | 24,899 | +193.7% | 0.05% | +116.7% |
| Q2 2021 | $702,000 | +21.5% | 8,479 | -2.8% | 0.02% | +9.1% |
| Q1 2021 | $578,000 | -23.8% | 8,720 | -11.9% | 0.02% | -33.3% |
| Q4 2020 | $759,000 | +90.2% | 9,893 | +6.8% | 0.03% | +57.1% |
| Q3 2020 | $399,000 | +56.5% | 9,266 | +56.8% | 0.02% | +50.0% |
| Q2 2020 | $255,000 | -57.7% | 5,909 | -37.9% | 0.01% | -46.2% |
| Q4 2019 | $603,000 | +123.3% | 9,514 | -0.6% | 0.03% | +85.7% |
| Q3 2019 | $270,000 | +9.8% | 9,568 | +3.0% | 0.01% | +16.7% |
| Q2 2019 | $246,000 | – | 9,290 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |